Annual CFI
-$32.28 B
-$16.50 B-104.51%
31 December 2023
Summary:
Pfizer annual cash flow from investing activities is currently -$32.28 billion, with the most recent change of -$16.50 billion (-104.51%) on 31 December 2023. During the last 3 years, it has fallen by -$28.01 billion (-655.75%). PFE annual CFI is now -624.50% below its all-time high of $6.15 billion, reached on 31 December 2012.PFE Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$2.06 B
-$6.66 B-144.72%
30 September 2024
Summary:
Pfizer quarterly cash flow from investing activities is currently -$2.06 billion, with the most recent change of -$6.66 billion (-144.72%) on 30 September 2024. Over the past year, it has dropped by -$2.94 billion (-331.64%). PFE quarterly CFI is now -121.28% below its all-time high of $9.67 billion, reached on 01 March 2018.PFE Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$6.72 B
-$2.94 B-77.99%
30 September 2024
Summary:
Pfizer TTM cash flow from investing activities is currently -$6.72 billion, with the most recent change of -$2.94 billion (-77.99%) on 30 September 2024. Over the past year, it has increased by +$18.97 billion (+73.84%). PFE TTM CFI is now -209.21% below its all-time high of $6.15 billion, reached on 31 December 2012.PFE TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -104.5% | -331.6% | +73.8% |
| 3 y3 years | -655.8% | +79.6% | +42.2% |
| 5 y5 years | -813.3% | +69.6% | -258.3% |
PFE Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -655.8% | at low | -144.7% | +91.9% | -78.0% | +80.2% |
| 5 y | 5 years | -813.3% | at low | -124.7% | +91.9% | -526.4% | +80.2% |
| alltime | all time | -624.5% | at low | -121.3% | +91.9% | -209.2% | +80.2% |
Pfizer Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.06 B(-144.7%) | -$6.72 B(+78.0%) |
| June 2024 | - | $4.60 B(+165.6%) | -$3.78 B(-88.8%) |
| Mar 2024 | - | $1.73 B(-115.8%) | -$33.86 B(+4.9%) |
| Dec 2023 | -$32.28 B(+104.5%) | -$11.00 B(-1338.3%) | -$32.28 B(+25.6%) |
| Sept 2023 | - | $888.00 M(-103.5%) | -$25.69 B(-5.6%) |
| June 2023 | - | -$25.48 B(-868.8%) | -$27.21 B(+108.7%) |
| Mar 2023 | - | $3.31 B(-175.2%) | -$13.04 B(-17.4%) |
| Dec 2022 | -$15.78 B(-30.0%) | -$4.41 B(+603.3%) | -$15.78 B(+13.1%) |
| Sept 2022 | - | -$627.00 M(-94.5%) | -$13.96 B(-40.4%) |
| June 2022 | - | -$11.31 B(-2095.2%) | -$23.41 B(+15.7%) |
| Mar 2022 | - | $567.00 M(-121.9%) | -$20.23 B(-10.3%) |
| Dec 2021 | -$22.55 B(+427.9%) | -$2.59 B(-74.3%) | -$22.55 B(+93.9%) |
| Sept 2021 | - | -$10.08 B(+23.8%) | -$11.63 B(+983.9%) |
| June 2021 | - | -$8.14 B(+365.8%) | -$1.07 B(-82.0%) |
| Mar 2021 | - | -$1.75 B(-121.0%) | -$5.95 B(+39.2%) |
| Dec 2020 | -$4.27 B(+8.3%) | $8.33 B(+1631.8%) | -$4.27 B(-72.3%) |
| Sept 2020 | - | $481.00 M(-103.7%) | -$15.43 B(-31.9%) |
| June 2020 | - | -$13.01 B(>+9900.0%) | -$22.68 B(+96.0%) |
| Mar 2020 | - | -$71.00 M(-97.5%) | -$11.57 B(+193.2%) |
| Dec 2019 | -$3.94 B(-187.2%) | -$2.83 B(-58.1%) | -$3.94 B(+110.3%) |
| Sept 2019 | - | -$6.76 B(+255.4%) | -$1.88 B(-194.7%) |
| June 2019 | - | -$1.90 B(-125.2%) | $1.98 B(-17.8%) |
| Mar 2019 | - | $7.55 B(-1088.2%) | $2.41 B(-46.8%) |
| Dec 2018 | $4.53 B(-195.5%) | -$764.00 M(-73.7%) | $4.53 B(+753.8%) |
| Sept 2018 | - | -$2.90 B(+97.0%) | $530.00 M(+25.3%) |
| June 2018 | - | -$1.47 B(-115.2%) | $423.00 M(+166.0%) |
| Mar 2018 | - | $9.67 B(-303.1%) | $159.00 M(-103.4%) |
| Dec 2017 | -$4.74 B(-39.2%) | -$4.76 B(+58.1%) | -$4.74 B(+54.5%) |
| Sept 2017 | - | -$3.01 B(+73.2%) | -$3.07 B(-30.9%) |
| June 2017 | - | -$1.74 B(-136.5%) | -$4.44 B(-39.8%) |
| Mar 2017 | - | $4.77 B(-254.5%) | -$7.38 B(-5.3%) |
| Dec 2016 | -$7.79 B(+161.4%) | -$3.09 B(-29.5%) | -$7.79 B(+12.5%) |
| Sept 2016 | - | -$4.38 B(-6.3%) | -$6.93 B(-11.1%) |
| June 2016 | - | -$4.68 B(-207.4%) | -$7.79 B(+49.3%) |
| Mar 2016 | - | $4.36 B(-295.8%) | -$5.22 B(+75.1%) |
| Dec 2015 | -$2.98 B(-47.3%) | -$2.22 B(-57.6%) | -$2.98 B(+31.3%) |
| Sept 2015 | - | -$5.24 B(+149.1%) | -$2.27 B(-618.3%) |
| June 2015 | - | -$2.10 B(-131.9%) | $438.00 M(-57.7%) |
| Mar 2015 | - | $6.59 B(-535.4%) | $1.04 B(-118.3%) |
| Dec 2014 | -$5.65 B(-46.4%) | -$1.51 B(-40.3%) | -$5.65 B(+41.4%) |
| Sept 2014 | - | -$2.54 B(+68.2%) | -$4.00 B(+93.5%) |
| June 2014 | - | -$1.51 B(+1437.8%) | -$2.07 B(-827.5%) |
| Mar 2014 | - | -$98.00 M(-169.0%) | $284.00 M(-102.7%) |
| Dec 2013 | -$10.54 B(-271.3%) | $142.00 M(-123.5%) | -$10.54 B(+173.9%) |
| Sept 2013 | - | -$603.00 M(-171.5%) | -$3.85 B(+10.2%) |
| June 2013 | - | $843.00 M(-107.7%) | -$3.49 B(-33.1%) |
| Mar 2013 | - | -$10.93 B(-259.8%) | -$5.22 B(-184.9%) |
| Dec 2012 | $6.15 B(+233.9%) | $6.84 B(-2868.0%) | $6.15 B(-4464.5%) |
| Sept 2012 | - | -$247.00 M(-72.2%) | -$141.00 M(-143.9%) |
| June 2012 | - | -$887.00 M(-296.7%) | $321.00 M(-79.5%) |
| Mar 2012 | - | $451.00 M(-16.8%) | $1.57 B(-14.9%) |
| Dec 2011 | $1.84 B(-474.6%) | $542.00 M(+152.1%) | $1.84 B(-142.4%) |
| Sept 2011 | - | $215.00 M(-40.4%) | -$4.34 B(-48.5%) |
| June 2011 | - | $361.00 M(-50.2%) | -$8.44 B(-7.9%) |
| Mar 2011 | - | $725.00 M(-112.8%) | -$9.16 B(+1762.0%) |
| Dec 2010 | -$492.00 M(-98.4%) | -$5.64 B(+45.5%) | -$492.00 M(-162.6%) |
| Sept 2010 | - | -$3.88 B(+974.8%) | $786.00 M(-82.0%) |
| June 2010 | - | -$361.00 M(-103.8%) | $4.37 B(-153.0%) |
| Mar 2010 | - | $9.39 B(-315.1%) | -$8.24 B(-73.6%) |
| Dec 2009 | -$31.27 B(+143.6%) | -$4.37 B(+1365.4%) | -$31.27 B(+5.3%) |
| Sept 2009 | - | -$298.00 M(-97.7%) | -$29.68 B(-2.7%) |
| June 2009 | - | -$12.97 B(-4.8%) | -$30.49 B(+45.3%) |
| Mar 2009 | - | -$13.63 B(+390.4%) | -$20.98 B(+63.5%) |
| Dec 2008 | -$12.84 B(-1714.5%) | -$2.78 B(+151.1%) | -$12.84 B(-0.1%) |
| Sept 2008 | - | -$1.11 B(-68.0%) | -$12.85 B(+9.9%) |
| June 2008 | - | -$3.46 B(-36.8%) | -$11.70 B(+30.6%) |
| Mar 2008 | - | -$5.48 B(+95.9%) | -$8.96 B(-1227.0%) |
| Dec 2007 | $795.00 M | -$2.80 B(-6055.3%) | $795.00 M(-80.3%) |
| Sept 2007 | - | $47.00 M(-106.5%) | $4.03 B(-6.9%) |
| June 2007 | - | -$724.00 M(-117.0%) | $4.33 B(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | $4.27 B(+881.8%) | $3.94 B(-22.7%) |
| Dec 2006 | $5.10 B(-200.6%) | $435.00 M(+26.5%) | $5.10 B(-263.9%) |
| Sept 2006 | - | $344.00 M(-131.0%) | -$3.11 B(-36.7%) |
| June 2006 | - | -$1.11 B(-120.4%) | -$4.92 B(-260.5%) |
| Mar 2006 | - | $5.43 B(-169.8%) | $3.06 B(-160.4%) |
| Dec 2005 | -$5.07 B(-46.2%) | -$7.78 B(+432.1%) | -$5.07 B(<-9900.0%) |
| Sept 2005 | - | -$1.46 B(-121.3%) | $18.00 M(-98.8%) |
| June 2005 | - | $6.87 B(-354.1%) | $1.52 B(-118.0%) |
| Mar 2005 | - | -$2.71 B(+0.6%) | -$8.41 B(-10.8%) |
| Dec 2004 | -$9.42 B(-294.3%) | -$2.69 B(-7367.6%) | -$9.42 B(+61.8%) |
| Sept 2004 | - | $37.00 M(-101.2%) | -$5.82 B(+1.2%) |
| June 2004 | - | -$3.05 B(-18.1%) | -$5.75 B(-291.0%) |
| Mar 2004 | - | -$3.72 B(-508.5%) | $3.01 B(-37.9%) |
| Dec 2003 | $4.85 B(-211.8%) | $911.00 M(+759.4%) | $4.85 B(+46.8%) |
| Sept 2003 | - | $106.00 M(-98.1%) | $3.30 B(+37.7%) |
| June 2003 | - | $5.72 B(-403.6%) | $2.40 B(-146.2%) |
| Mar 2003 | - | -$1.88 B(+196.1%) | -$5.19 B(+19.7%) |
| Dec 2002 | -$4.34 B(-39.2%) | -$636.00 M(-20.4%) | -$4.34 B(-23.5%) |
| Sept 2002 | - | -$799.00 M(-57.3%) | -$5.67 B(-9.9%) |
| June 2002 | - | -$1.87 B(+81.8%) | -$6.29 B(-8.9%) |
| Mar 2002 | - | -$1.03 B(-47.6%) | -$6.91 B(-3.2%) |
| Dec 2001 | -$7.13 B(+90.1%) | -$1.97 B(+38.0%) | -$7.13 B(+28.3%) |
| Sept 2001 | - | -$1.42 B(-42.7%) | -$5.56 B(-8.1%) |
| June 2001 | - | -$2.49 B(+97.5%) | -$6.06 B(+54.1%) |
| Mar 2001 | - | -$1.26 B(+220.4%) | -$3.93 B(+4.7%) |
| Dec 2000 | -$3.75 B(-3.9%) | -$393.00 M(-79.5%) | -$3.75 B(+12.5%) |
| Sept 2000 | - | -$1.92 B(+429.6%) | -$3.33 B(-0.9%) |
| June 2000 | - | -$362.00 M(-66.5%) | -$3.37 B(-15.1%) |
| Mar 2000 | - | -$1.08 B(-4424.0%) | -$3.96 B(+1.5%) |
| Dec 1999 | -$3.91 B(+408.6%) | $25.00 M(-101.3%) | -$3.91 B(-33.5%) |
| Sept 1999 | - | -$1.95 B(+102.6%) | -$5.88 B(+137.6%) |
| June 1999 | - | -$961.00 M(-6.1%) | -$2.47 B(+26.9%) |
| Mar 1999 | - | -$1.02 B(-47.5%) | -$1.95 B(+153.9%) |
| Dec 1998 | -$768.00 M(-20.2%) | -$1.95 B(-233.6%) | -$768.00 M(-179.5%) |
| Sept 1998 | - | $1.46 B(-433.4%) | $966.00 M(-246.1%) |
| June 1998 | - | -$437.00 M(-374.8%) | -$661.00 M(+39.7%) |
| Mar 1998 | - | $159.00 M(-174.6%) | -$473.00 M(-50.9%) |
| Dec 1997 | -$963.00 M(+13.3%) | -$213.00 M(+25.3%) | -$963.00 M(+124.5%) |
| Sept 1997 | - | -$170.00 M(-31.7%) | -$429.00 M(-61.5%) |
| June 1997 | - | -$249.00 M(-24.8%) | -$1.11 B(-23.0%) |
| Mar 1997 | - | -$331.00 M(-203.1%) | -$1.45 B(+70.1%) |
| Dec 1996 | -$850.00 M(-63.7%) | $321.00 M(-137.6%) | -$850.00 M(-44.2%) |
| Sept 1996 | - | -$854.00 M(+46.7%) | -$1.52 B(+116.8%) |
| June 1996 | - | -$582.00 M(-319.6%) | -$702.50 M(+69.8%) |
| Mar 1996 | - | $265.00 M(-175.2%) | -$413.70 M(-82.3%) |
| Dec 1995 | -$2.34 B(+178.8%) | -$352.20 M(+957.7%) | -$2.34 B(+7.8%) |
| Sept 1995 | - | -$33.30 M(-88.6%) | -$2.17 B(-5.8%) |
| June 1995 | - | -$293.20 M(-82.4%) | -$2.31 B(-4.7%) |
| Mar 1995 | - | -$1.66 B(+809.3%) | -$2.42 B(+188.2%) |
| Dec 1994 | -$840.30 M(+326.8%) | -$183.00 M(+9.8%) | -$840.30 M(+47.3%) |
| Sept 1994 | - | -$166.60 M(-59.1%) | -$570.30 M(+31.9%) |
| June 1994 | - | -$407.80 M(+391.9%) | -$432.50 M(-2199.5%) |
| Mar 1994 | - | -$82.90 M(-195.3%) | $20.60 M(-110.5%) |
| Dec 1993 | -$196.90 M(-150.5%) | $87.00 M(-402.1%) | -$196.90 M(-413.0%) |
| Sept 1993 | - | -$28.80 M(-163.6%) | $62.90 M(-169.5%) |
| June 1993 | - | $45.30 M(-115.1%) | -$90.50 M(+3.2%) |
| Mar 1993 | - | -$300.40 M(-186.6%) | -$87.70 M(-122.5%) |
| Dec 1992 | $389.90 M(-411.4%) | $346.80 M(-290.3%) | $389.90 M(+124.6%) |
| Sept 1992 | - | -$182.20 M(-478.8%) | $173.60 M(-17.4%) |
| June 1992 | - | $48.10 M(-72.9%) | $210.10 M(-555.7%) |
| Mar 1992 | - | $177.20 M(+35.8%) | -$46.10 M(-63.2%) |
| Dec 1991 | -$125.20 M(-61.9%) | $130.50 M(-189.6%) | -$125.20 M(-46.1%) |
| Sept 1991 | - | -$145.70 M(-30.0%) | -$232.10 M(-32.6%) |
| June 1991 | - | -$208.10 M(-312.1%) | -$344.60 M(+4.7%) |
| Mar 1991 | - | $98.10 M(+315.7%) | -$329.10 M(+0.0%) |
| Dec 1990 | -$329.00 M(-47.5%) | $23.60 M(-109.1%) | -$329.00 M(-6.7%) |
| Sept 1990 | - | -$258.20 M(+34.1%) | -$352.60 M(+273.5%) |
| June 1990 | - | -$192.60 M(-296.1%) | -$94.40 M(-196.1%) |
| Mar 1990 | - | $98.20 M | $98.20 M |
| Dec 1989 | -$626.80 M | - | - |
FAQ
- What is Pfizer annual cash flow from investing activities?
- What is the all time high annual CFI for Pfizer?
- What is Pfizer annual CFI year-on-year change?
- What is Pfizer quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Pfizer?
- What is Pfizer quarterly CFI year-on-year change?
- What is Pfizer TTM cash flow from investing activities?
- What is the all time high TTM CFI for Pfizer?
- What is Pfizer TTM CFI year-on-year change?
What is Pfizer annual cash flow from investing activities?
The current annual CFI of PFE is -$32.28 B
What is the all time high annual CFI for Pfizer?
Pfizer all-time high annual cash flow from investing activities is $6.15 B
What is Pfizer annual CFI year-on-year change?
Over the past year, PFE annual cash flow from investing activities has changed by -$16.50 B (-104.51%)
What is Pfizer quarterly cash flow from investing activities?
The current quarterly CFI of PFE is -$2.06 B
What is the all time high quarterly CFI for Pfizer?
Pfizer all-time high quarterly cash flow from investing activities is $9.67 B
What is Pfizer quarterly CFI year-on-year change?
Over the past year, PFE quarterly cash flow from investing activities has changed by -$2.94 B (-331.64%)
What is Pfizer TTM cash flow from investing activities?
The current TTM CFI of PFE is -$6.72 B
What is the all time high TTM CFI for Pfizer?
Pfizer all-time high TTM cash flow from investing activities is $6.15 B
What is Pfizer TTM CFI year-on-year change?
Over the past year, PFE TTM cash flow from investing activities has changed by +$18.97 B (+73.84%)